VANGUARD GROUP INC - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 26 filers reported holding PROTEON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$36,000
+56.5%
88,1840.0%0.00%
Q3 2019$23,000
-37.8%
88,1840.0%0.00%
Q2 2019$37,000
-68.6%
88,184
-62.3%
0.00%
Q1 2019$118,000
-76.2%
233,953
+7.2%
0.00%
Q4 2018$495,000
+21.3%
218,153
+4.2%
0.00%
Q3 2018$408,000
+15.9%
209,383
+45.9%
0.00%
Q2 2018$352,000
-32.3%
143,550
-31.0%
0.00%
Q1 2018$520,000
+30.3%
208,074
-1.1%
0.00%
Q4 2017$399,000
-4.3%
210,374
+0.9%
0.00%
Q3 2017$417,000
+34.5%
208,434
+4.5%
0.00%
Q2 2017$310,000
-25.5%
199,529
-16.1%
0.00%
Q1 2017$416,000
+14.6%
237,929
+24.3%
0.00%
Q4 2016$363,000
-73.5%
191,361
+30.1%
0.00%
Q3 2016$1,372,000
+27.3%
147,041
+9.5%
0.00%
Q2 2016$1,078,000
-6.6%
134,241
-10.0%
0.00%
Q1 2016$1,154,000
-49.9%
149,172
+0.4%
0.00%
Q4 2015$2,305,000
+13.5%
148,596
+1.8%
0.00%
Q3 2015$2,031,000
-35.0%
146,018
-16.5%
0.00%
Q2 2015$3,125,000
+31.1%
174,925
-14.7%
0.00%
Q1 2015$2,384,000
+20.8%
205,010
+8.1%
0.00%
Q4 2014$1,973,000189,7200.00%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$27,423,00016.02%
Monashee Investment Management LLC 77,102$1,072,0007.40%
Deer VII & Co. Ltd. 315,101$4,383,0004.15%
RA Capital Management 1,506,872$20,961,0003.01%
MPM ASSET MANAGEMENT LLC 983,381$13,679,0002.10%
Omega Fund Management, LLC 250,000$3,478,0001.96%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,343$17,601,0000.68%
Perceptive Advisors 550,000$7,650,0000.31%
TIVERTON ASSET MANAGEMENT LLC 375,000$5,216,0000.12%
Baker Brothers Advisors 274,617$3,820,0000.04%
View complete list of PROTEON THERAPEUTICS INC shareholders